首页 > 最新文献

Journal of Research in Pharmacy Practice最新文献

英文 中文
Consumer's Satisfaction with Community Pharmacies in Sindh, Pakistan. 巴基斯坦信德省消费者对社区药房的满意度。
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-08-03 eCollection Date: 2021-04-01 DOI: 10.4103/jrpp.JRPP_20_108
Yun Jin Kim, Muhammad Shahzad Aslam, Syed Muhammad Fahim, Waris Ali Khan, Linchao Qian

Objective: The present research is the first comprehensive cross-sectional study of consumer satisfaction with community pharmacies in Sindh, Pakistan. Moreover, the study has also designed a nonorder theoretical model for consumer satisfaction with community pharmacies.

Methods: This is a cross-sectional descriptive study from a general population of Sindh, Pakistan, with a total of four hundred and fifteen (n = 415) participants. A confirmatory factor analysis was used to verify the factor structure between Pharmaceutical services (PS), the Skill of Pharmacists, Non-pharmaceutical services (NPS), and pricing (P). Pearson correlation analysis, Kendall's tau correlation analysis, and Spearman's rho correlation analysis were used to identify the correlation between different factors, such as PS, SKP, NPS, and P.

Findings: The 23-item scale that consisted of four elements have shown an acceptable root mean squared error of approximation (0.076), Cronbach's alpha (0.787), and Chi-square value (3.381) (P < 0.001). Of the respondents, 56.4% rated their satisfaction on pharmacist attitude, whereas 67.2%, 41.4%, and 51.8% were satisfied with other services, such as receipt provided on medication they take, prescription drug service and availability of pharmacies on the weekend and public holidays, respectively.

Conclusion: This cross-sectional study confirms that there are relationships among PS, SPK, NPS, and P. Moreover, there is a lack of facilities in community pharmacies in Sindh, such as the unavailability of a consultation room, immunization services, information on routine health matters, and medication record.

研究目的本研究是首次对巴基斯坦信德省消费者对社区药房的满意度进行全面的横断面研究。此外,本研究还设计了一个消费者对社区药房满意度的无序理论模型:这是一项横断面描述性研究,研究对象是巴基斯坦信德省的普通人群,共有四百一十五名参与者(n = 415)。研究采用了确认性因子分析来验证制药服务(PS)、药剂师技能、非制药服务(NPS)和定价(P)之间的因子结构。使用了皮尔逊相关分析、肯德尔头相关分析和斯皮尔曼 rho 相关分析来确定不同因子(如 PS、SKP、NPS 和 P)之间的相关性:由四个要素组成的 23 个项目量表的均方根近似误差(0.076)、克朗巴赫α值(0.787)和奇偶校验值(3.381)(P < 0.001)均可接受。在受访者中,56.4% 的人对药剂师的态度表示满意,而 67.2%、41.4% 和 51.8% 的人对其他服务表示满意,如提供服用药物的收据、处方药服务以及周末和公共节假日药房的供应情况等:这项横断面研究证实了 PS、SPK、NPS 和 P 之间的关系。此外,信德省的社区药房还存在设施不足的问题,如没有咨询室、免疫接种服务、常规健康信息和用药记录。
{"title":"Consumer's Satisfaction with Community Pharmacies in Sindh, Pakistan.","authors":"Yun Jin Kim, Muhammad Shahzad Aslam, Syed Muhammad Fahim, Waris Ali Khan, Linchao Qian","doi":"10.4103/jrpp.JRPP_20_108","DOIUrl":"10.4103/jrpp.JRPP_20_108","url":null,"abstract":"<p><strong>Objective: </strong>The present research is the first comprehensive cross-sectional study of consumer satisfaction with community pharmacies in Sindh, Pakistan. Moreover, the study has also designed a nonorder theoretical model for consumer satisfaction with community pharmacies.</p><p><strong>Methods: </strong>This is a cross-sectional descriptive study from a general population of Sindh, Pakistan, with a total of four hundred and fifteen (<i>n</i> = 415) participants. A confirmatory factor analysis was used to verify the factor structure between Pharmaceutical services (PS), the Skill of Pharmacists, Non-pharmaceutical services (NPS), and pricing (P). Pearson correlation analysis, Kendall's tau correlation analysis, and Spearman's rho correlation analysis were used to identify the correlation between different factors, such as PS, SKP, NPS, and P.</p><p><strong>Findings: </strong>The 23-item scale that consisted of four elements have shown an acceptable root mean squared error of approximation (0.076), Cronbach's alpha (0.787), and Chi-square value (3.381) (<i>P</i> < 0.001). Of the respondents, 56.4% rated their satisfaction on pharmacist attitude, whereas 67.2%, 41.4%, and 51.8% were satisfied with other services, such as receipt provided on medication they take, prescription drug service and availability of pharmacies on the weekend and public holidays, respectively.</p><p><strong>Conclusion: </strong>This cross-sectional study confirms that there are relationships among PS, SPK, NPS, and P. Moreover, there is a lack of facilities in community pharmacies in Sindh, such as the unavailability of a consultation room, immunization services, information on routine health matters, and medication record.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"78-82"},"PeriodicalIF":0.8,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9b/99/JRPP-10-78.PMC8420935.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of 2 mg Versus 4 mg of Intravenous Zoledronic Acid on Bone Mineral Density at the Lumbar Spine in Indian Postmenopausal Women with Osteoporosis: A Double-blind Parallel-arm Randomized Controlled Trial. 静脉注射2mg与4mg唑来膦酸对印度绝经后骨质疏松症妇女腰椎骨密度的影响:一项双盲平行随机对照试验
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-08-03 eCollection Date: 2021-04-01 DOI: 10.4103/jrpp.JRPP_20_130
Harsh Durgia, Sadishkumar Kamalanathan, Govindarajalou Ramkumar, Sonali Sarkar, Sagili Vihaya Bhaskar Reddy, Jayaprakash Sahoo, Rajan Palui, Henith Raj

Objective: The primary purpose was to compare the effect of 2 mg and 4 mg of intravenous zoledronic acid (ZA) on change in the lumbar spine (LS) bone mineral density (BMD) at the end of 1 year in postmenopausal women with osteoporosis. The secondary objectives were changes in BMD at the total hip and femoral neck, change in bone turnover markers (BTMs), and the incidence of new fractures.

Methods: This was a double-blind, parallel-arm, randomized control trial with an allocation ratio of 1:1 done in 70 postmenopausal women with osteoporosis.

Findings: The mean (±standard deviation) percentage increase in LS BMD at the end of 1 year was 4.86% ± 3.05% and 5.35% ± 3.73% in the 2 mg and 4 mg group, respectively. The dose of 2 mg ZA proved to be inferior to 4 mg with a noninferiority margin of 0.5%. There was no difference in BMD change at hip and BTMs between the two groups at the end of 1 year. Only one patient in 4 mg group developed two new vertebral fractures during a 12-month follow-up. Acute-phase reactions were the most common (43%) side-effects noted without any difference between the two groups (P = 0.63).

Conclusion: This study failed to show the noninferiority of 2 mg ZA compared to 4 mg ZA for change in LS BMD at the end of 1 year.

目的:主要目的是比较静脉注射2 mg和4 mg唑来膦酸(ZA)对绝经后骨质疏松症妇女1年后腰椎(LS)骨密度(BMD)变化的影响。次要目标是全髋关节和股骨颈的骨密度变化,骨转换标志物(BTMs)的变化以及新骨折的发生率。方法:这是一项双盲、平行组、随机对照试验,分配比例为1:1,在70名绝经后骨质疏松症妇女中进行。结果:2 mg和4 mg组1年后LS骨密度的平均(±标准差)百分比分别为4.86%±3.05%和5.35%±3.73%。2mg ZA的剂量低于4mg,非劣效边际为0.5%。1年后,两组患者髋部骨密度变化及btm无差异。在12个月的随访中,4mg组只有1例患者出现了两次新的椎体骨折。急性期反应是最常见的副作用(43%),两组间无差异(P = 0.63)。结论:本研究未能显示2 mg ZA与4 mg ZA在1年后对LS BMD变化的非劣效性。
{"title":"Effect of 2 mg Versus 4 mg of Intravenous Zoledronic Acid on Bone Mineral Density at the Lumbar Spine in Indian Postmenopausal Women with Osteoporosis: A Double-blind Parallel-arm Randomized Controlled Trial.","authors":"Harsh Durgia,&nbsp;Sadishkumar Kamalanathan,&nbsp;Govindarajalou Ramkumar,&nbsp;Sonali Sarkar,&nbsp;Sagili Vihaya Bhaskar Reddy,&nbsp;Jayaprakash Sahoo,&nbsp;Rajan Palui,&nbsp;Henith Raj","doi":"10.4103/jrpp.JRPP_20_130","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_130","url":null,"abstract":"<p><strong>Objective: </strong>The primary purpose was to compare the effect of 2 mg and 4 mg of intravenous zoledronic acid (ZA) on change in the lumbar spine (LS) bone mineral density (BMD) at the end of 1 year in postmenopausal women with osteoporosis. The secondary objectives were changes in BMD at the total hip and femoral neck, change in bone turnover markers (BTMs), and the incidence of new fractures.</p><p><strong>Methods: </strong>This was a double-blind, parallel-arm, randomized control trial with an allocation ratio of 1:1 done in 70 postmenopausal women with osteoporosis.</p><p><strong>Findings: </strong>The mean (±standard deviation) percentage increase in LS BMD at the end of 1 year was 4.86% ± 3.05% and 5.35% ± 3.73% in the 2 mg and 4 mg group, respectively. The dose of 2 mg ZA proved to be inferior to 4 mg with a noninferiority margin of 0.5%. There was no difference in BMD change at hip and BTMs between the two groups at the end of 1 year. Only one patient in 4 mg group developed two new vertebral fractures during a 12-month follow-up. Acute-phase reactions were the most common (43%) side-effects noted without any difference between the two groups (<i>P</i> = 0.63).</p><p><strong>Conclusion: </strong>This study failed to show the noninferiority of 2 mg ZA compared to 4 mg ZA for change in LS BMD at the end of 1 year.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"71-77"},"PeriodicalIF":1.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4f/97/JRPP-10-71.PMC8420937.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Efficacy of the Combination of Indomethacin and Methocarbamol versus Indomethacin Alone in Patients with Acute Low Back Pain: A Double-Blind, Randomized Placebo-Controlled Clinical Trial. 吲哚美辛联合甲氨基氨基酚与单用吲哚美辛治疗急性腰痛的疗效比较:一项双盲、随机安慰剂对照临床试验
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-08-03 eCollection Date: 2021-04-01 DOI: 10.4103/jrpp.JRPP_21_31
Shiva Samsamshariat, Mehdi Sharifi-Sade, Shafeajafar Zoofaghari, Asieh Maghami Mehr, Ali Mohammad Sabzghabaee

Objective: Acute low back pain is a common ailment and causes pain and disability. Physicians often prescribe nonsteroidal anti-inflammatory drugs (NSAIDs) to treat acute low back pain; however, due attention has recently been drawn to muscle relaxants to reduce the severity of patients' daily physical dysfunction. Therefore, this study aimed to evaluate the therapeutic effect of the administration of indomethacin alone compared with methocarbamolas a muscle relaxant and indomethacin as an NSAID on the treatment of acute low back pain.

Methods: The present double-blind clinical trial was performed on 64 patients with acute low back pain. The patients were categorized into two groups and received the treatments as follows. Indomethacin capsules of 25 mg every 8 h and placebo tablets every 8 h were administered in the first group (Group I). Indomethacin capsules of 25 mg every 8 h and methocarbamol tablets of 500 mg every 8 h were administered in the second group (Group I + M). Patient pain intensity and physical function based on Back Pain Function Scale (BPFS) were recorded before and 1 week after the intervention.

Findings: The present study results revealed that the mean pain reduction of patients in Group I + M was significantly higher than that of Group I (3.66 ± 3.17 vs. 1.84 ± 1.53; P < 0.001). Moreover, the mean BPFS increase in Group I + M was significantly higher than that of Group I (19.44 ± 8.66 vs. 4.75 ± 4.35; P < 0.001).

Conclusion: According to the results of the present study, concomitant administration of indomethacin and methocarbamol can be more effective in reducing pain intensity and improving the patient's physical function (or performance).

目的:急性腰痛是一种常见的疾病,可引起疼痛和残疾。医生经常开非甾体抗炎药(NSAIDs)来治疗急性腰痛;然而,肌肉松弛剂最近引起了人们的注意,以减轻患者日常身体功能障碍的严重程度。因此,本研究旨在评价单独应用吲哚美辛与肌松剂甲氧甲氨酰胺及吲哚美辛作为非甾体抗炎药治疗急性腰痛的疗效。方法:对64例急性腰痛患者进行双盲临床试验。将患者分为两组,采用如下治疗方法。第一组(I组)给予吲哚美辛胶囊25 mg / 8 h,安慰剂片每8 h,第二组(I + M组)给予吲哚美辛胶囊25 mg / 8 h,甲氨氨基酚片500 mg / 8 h,分别于干预前和干预后1周记录患者疼痛强度和背部疼痛功能量表(BPFS)生理功能。结果:本研究结果显示,I + M组患者的平均疼痛减轻程度显著高于I组(3.66±3.17∶1.84±1.53;P < 0.001)。此外,I + M组BPFS的平均增幅显著高于I组(19.44±8.66∶4.75±4.35;P < 0.001)。结论:根据本研究结果,吲哚美辛与甲氨基酚合用能更有效地减轻疼痛强度,改善患者的身体机能(或工作表现)。
{"title":"Efficacy of the Combination of Indomethacin and Methocarbamol versus Indomethacin Alone in Patients with Acute Low Back Pain: A Double-Blind, Randomized Placebo-Controlled Clinical Trial.","authors":"Shiva Samsamshariat,&nbsp;Mehdi Sharifi-Sade,&nbsp;Shafeajafar Zoofaghari,&nbsp;Asieh Maghami Mehr,&nbsp;Ali Mohammad Sabzghabaee","doi":"10.4103/jrpp.JRPP_21_31","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_31","url":null,"abstract":"<p><strong>Objective: </strong>Acute low back pain is a common ailment and causes pain and disability. Physicians often prescribe nonsteroidal anti-inflammatory drugs (NSAIDs) to treat acute low back pain; however, due attention has recently been drawn to muscle relaxants to reduce the severity of patients' daily physical dysfunction. Therefore, this study aimed to evaluate the therapeutic effect of the administration of indomethacin alone compared with methocarbamolas a muscle relaxant and indomethacin as an NSAID on the treatment of acute low back pain.</p><p><strong>Methods: </strong>The present double-blind clinical trial was performed on 64 patients with acute low back pain. The patients were categorized into two groups and received the treatments as follows. Indomethacin capsules of 25 mg every 8 h and placebo tablets every 8 h were administered in the first group (Group I). Indomethacin capsules of 25 mg every 8 h and methocarbamol tablets of 500 mg every 8 h were administered in the second group (Group I + M). Patient pain intensity and physical function based on Back Pain Function Scale (BPFS) were recorded before and 1 week after the intervention.</p><p><strong>Findings: </strong>The present study results revealed that the mean pain reduction of patients in Group I + M was significantly higher than that of Group I (3.66 ± 3.17 vs. 1.84 ± 1.53; <i>P</i> < 0.001). Moreover, the mean BPFS increase in Group I + M was significantly higher than that of Group I (19.44 ± 8.66 vs. 4.75 ± 4.35; <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>According to the results of the present study, concomitant administration of indomethacin and methocarbamol can be more effective in reducing pain intensity and improving the patient's physical function (or performance).</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"96-101"},"PeriodicalIF":1.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/ae/JRPP-10-96.PMC8420930.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment Methods and Competency Mapping in Pharmacy Education: Understanding of Components and Quality Parameters. 药学教育的评估方法和能力映射:对成分和质量参数的理解。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-08-03 eCollection Date: 2021-04-01 DOI: 10.4103/jrpp.JRPP_21_29
Syed Wasif Gillani, Kishore Gnana Sam, Fithawit Bahran Gebreigziabher, Jumana Al-Salloum, Rizah Anwar Assadi, Shabaz Mohiuddin Gulam

Centre of advanced pharmaceutical education have developed 15 subsets of competencies required to be competent pharmacist and able to provide optimum care. These competencies were further categorized; Level 1 intermediate, Level 2 efficient, and Level 3 professional. These competencies are cross-mapped to achieve desirable outcomes. Where personal and professional development skills incorporate knowledge, for being a holistic pharmacist. In healthcare education curriculums, active learning tools such as simulation-based patient cases and other innovative learning activities are used to teach clinical skills, patient assessments, and pharmacotherapy concepts. The advance team-based learning technique for the development of stepwise understanding of disease management (simple-complex cases) and students can communicate and collaborate for the critical thinking and decision-making process. Many studies showed the positive impact of the peer teaching on the students; enhanced their academic performance, increase the cognitive congruence, and allows the students to share their own learning struggles to come up with solutions to overcome these challenges. Pharmacy is a healthcare professional required intensive training and professional skills to provide optimum care to patients. The emerging clinical role of pharmacy focused on the patient-centered model, comprehensive assessment, and teaching methods are required to fulfill the professional competencies.

高级药学教育中心开发了15个能力子集,需要成为合格的药剂师,能够提供最佳的护理。这些能力被进一步分类;1级中级,2级高效,3级专业。这些能力是交叉映射的,以实现理想的结果。个人和专业发展技能结合知识,成为一名整体药剂师。在医疗保健教育课程中,主动学习工具(如基于模拟的患者病例和其他创新学习活动)用于教授临床技能、患者评估和药物治疗概念。先进的以团队为基础的学习技术,有助于逐步理解疾病管理(简单到复杂的病例),学生可以在批判性思维和决策过程中进行沟通和协作。许多研究表明同伴教学对学生产生了积极的影响;提高了他们的学习成绩,增加了认知一致性,并允许学生分享自己的学习困难,想出解决这些挑战的办法。药剂学是一种医疗保健专业,需要密集的培训和专业技能来为患者提供最佳的护理。以患者为中心的模式、综合评估和教学方法是满足专业能力的必要条件。
{"title":"Assessment Methods and Competency Mapping in Pharmacy Education: Understanding of Components and Quality Parameters.","authors":"Syed Wasif Gillani,&nbsp;Kishore Gnana Sam,&nbsp;Fithawit Bahran Gebreigziabher,&nbsp;Jumana Al-Salloum,&nbsp;Rizah Anwar Assadi,&nbsp;Shabaz Mohiuddin Gulam","doi":"10.4103/jrpp.JRPP_21_29","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_29","url":null,"abstract":"<p><p>Centre of advanced pharmaceutical education have developed 15 subsets of competencies required to be competent pharmacist and able to provide optimum care. These competencies were further categorized; Level 1 intermediate, Level 2 efficient, and Level 3 professional. These competencies are cross-mapped to achieve desirable outcomes. Where personal and professional development skills incorporate knowledge, for being a holistic pharmacist. In healthcare education curriculums, active learning tools such as simulation-based patient cases and other innovative learning activities are used to teach clinical skills, patient assessments, and pharmacotherapy concepts. The advance team-based learning technique for the development of stepwise understanding of disease management (simple-complex cases) and students can communicate and collaborate for the critical thinking and decision-making process. Many studies showed the positive impact of the peer teaching on the students; enhanced their academic performance, increase the cognitive congruence, and allows the students to share their own learning struggles to come up with solutions to overcome these challenges. Pharmacy is a healthcare professional required intensive training and professional skills to provide optimum care to patients. The emerging clinical role of pharmacy focused on the patient-centered model, comprehensive assessment, and teaching methods are required to fulfill the professional competencies.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"102-105"},"PeriodicalIF":1.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7e/0a/JRPP-10-102.PMC8420934.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Pattern of Medication Usage in the Southern Region of Iran: A population-based Pharmacoepidemiological Study. 伊朗南部地区药物使用模式:基于人群的药物流行病学研究。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-08-03 eCollection Date: 2021-04-01 DOI: 10.4103/jrpp.JRPP_21_5
Marziyeh Zare, Saba Afifi, Amir Hossein Alizadeh Bahmani, Iman Karimzadeh, Mohammad Salehi-Marzijarani, Leila Zarei, Behnam Honarvar, Sulmaz Ghahremani, Kamran B Lankarani, Ali Mohammad Sabzghabaee, Payam Peymani

Objective: The purpose of this study was to document the demographic data, to assess the proportion of consumed medicines and the amounts and types of drugs available to households, and to to estimate the probable prevalence of certain diseases in the southern region of Iran.

Methods: In this cross-sectional population-based study carried out in Shiraz (the central city in the Southern part of Iran), we documented and evaluated the drug usage details in a random sample of 1000 households during 2018-2020. We analyzed the usage of drug categories based on the anatomical therapeutic chemical classification, which the World Health Organization recommends.

Findings: In the studied population, the average age (± standard deviation) was 45.54 ± 15.82, ranged 18-91 years. More than 90% had medical insurance coverage. About 81.8% of the participants had individual family medicine practitioners, and most of them (93.8%) received medications with a physician's prescription. The most frequently used medications were cough and cold preparations (12.9%), nervous system drugs (12.6%), and cardiovascular system drugs (11.6%).

Conclusion: Despite the easy access to medications for most participants, few individuals (about 6%) received their medications without a prescription. The most frequently prescribed medicines were the common cold, acetaminophen, and metformin. Common cold, gastrointestinal (GI) disorder, and diabetes were the most commonly used medication classes. Furthermore, we have found a probably higher than average prevalence of cardiovascular, GI, and endocrine disorders. This information could be used by the local policymakers as a basis for the estimation and allotment of health-care resources.

目的:本研究的目的是记录人口数据,评估所消耗药物的比例以及家庭可获得药物的数量和种类,并估计伊朗南部地区某些疾病的可能流行情况。方法:在设拉子(伊朗南部中心城市)进行的这项基于人口的横断面研究中,我们记录并评估了2018-2020年期间1000个家庭的随机样本中的药物使用细节。我们根据世界卫生组织推荐的解剖治疗化学分类分析了药物类别的使用情况。结果:研究人群平均年龄(±标准差)为45.54±15.82岁,年龄范围为18-91岁。90%以上的人有医疗保险。约81.8%的受访者曾个别聘用家庭医生,其中大部份(93.8%)是凭医生处方服药。最常用的药物是咳嗽和感冒药(12.9%)、神经系统药物(12.6%)和心血管系统药物(11.6%)。结论:尽管大多数参与者很容易获得药物,但很少有人(约6%)在没有处方的情况下接受药物治疗。最常见的处方药是普通感冒药、对乙酰氨基酚和二甲双胍。普通感冒、胃肠道(GI)紊乱和糖尿病是最常用的药物类别。此外,我们还发现心血管、胃肠道和内分泌疾病的患病率可能高于平均水平。这些信息可被地方决策者用作估计和分配保健资源的基础。
{"title":"The Pattern of Medication Usage in the Southern Region of Iran: A population-based Pharmacoepidemiological Study.","authors":"Marziyeh Zare,&nbsp;Saba Afifi,&nbsp;Amir Hossein Alizadeh Bahmani,&nbsp;Iman Karimzadeh,&nbsp;Mohammad Salehi-Marzijarani,&nbsp;Leila Zarei,&nbsp;Behnam Honarvar,&nbsp;Sulmaz Ghahremani,&nbsp;Kamran B Lankarani,&nbsp;Ali Mohammad Sabzghabaee,&nbsp;Payam Peymani","doi":"10.4103/jrpp.JRPP_21_5","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_5","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to document the demographic data, to assess the proportion of consumed medicines and the amounts and types of drugs available to households, and to to estimate the probable prevalence of certain diseases in the southern region of Iran.</p><p><strong>Methods: </strong>In this cross-sectional population-based study carried out in Shiraz (the central city in the Southern part of Iran), we documented and evaluated the drug usage details in a random sample of 1000 households during 2018-2020. We analyzed the usage of drug categories based on the anatomical therapeutic chemical classification, which the World Health Organization recommends.</p><p><strong>Findings: </strong>In the studied population, the average age (± standard deviation) was 45.54 ± 15.82, ranged 18-91 years. More than 90% had medical insurance coverage. About 81.8% of the participants had individual family medicine practitioners, and most of them (93.8%) received medications with a physician's prescription. The most frequently used medications were cough and cold preparations (12.9%), nervous system drugs (12.6%), and cardiovascular system drugs (11.6%).</p><p><strong>Conclusion: </strong>Despite the easy access to medications for most participants, few individuals (about 6%) received their medications without a prescription. The most frequently prescribed medicines were the common cold, acetaminophen, and metformin. Common cold, gastrointestinal (GI) disorder, and diabetes were the most commonly used medication classes. Furthermore, we have found a probably higher than average prevalence of cardiovascular, GI, and endocrine disorders. This information could be used by the local policymakers as a basis for the estimation and allotment of health-care resources.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"83-89"},"PeriodicalIF":1.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7d/c3/JRPP-10-83.PMC8420931.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Assessing the Performance of Community Pharmacies in Iran by Measuring Responsiveness to Non-Medical Needs: An Application of WHO Responsiveness Framework. 通过衡量对非医疗需求的反应性来评估伊朗社区药房的绩效:世卫组织反应性框架的应用。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-08-03 eCollection Date: 2021-04-01 DOI: 10.4103/jrpp.JRPP_21_23
Saba Afifi, Amir Hossein Alizadeh Bahmani, Leila Zarei, Motahareh Mahi-Birjand, Mehdi Hoorang, Marziyeh Zare, Iman Karimzadeh, Farzad Peiravian, Mahtabalsadat Mirjalili, Payam Peymani

Objective: Despite growing debates about the health systems' nonmedical performance, there has not been any empirical research on nonmedical performance and patients' rights consideration as a driver of human rights in the pharmaceutical sector. This study's main objective was to assess the nonmedical performance of community pharmacies of Shiraz, Iran.

Methods: A cross-sectional study was conducted using two self-administrated Likert-based questionnaires based on the World Health Organization (WHO) responsiveness framework and the legal charter communicated by the Ministry of Health and Medical Education of Iran. The population was patients older than 18 years who took a prescription from community pharmacies located in Shiraz and willing to answer the questions voluntarily, from 2018 to 2019. Considering the weights of subdimensions of responsiveness provided by the WHO framework, the total score of responsiveness was calculated ranging from 0 to 100.

Findings: The response rate was 80.5%. The mean (standard deviation) overall score of responsiveness was 57.18 (21.61), with a median of 56.71. The mean score of client orientation was lower in respondents with a high education level than those with a diploma and under diploma (P = 0.028).

Conclusion: Nonmedical pharmacy performance was considered either medium or high in more than half of the cases based on the participants' views. Regarding client, orientation was seen less often in patients with high education level compared to those with a lower education level.

目的:尽管关于卫生系统的非医疗绩效的争论越来越多,但没有任何关于非医疗绩效和患者权利考虑作为制药部门人权驱动因素的实证研究。本研究的主要目的是评估伊朗设拉子社区药房的非医疗绩效。方法:采用基于世界卫生组织(WHO)响应框架和伊朗卫生和医学教育部发布的法律章程的两份自我管理的李克特问卷进行横断面研究。在2018年至2019年期间,研究对象是18岁以上的患者,他们从设拉子的社区药店取了处方,并愿意自愿回答问题。考虑到世卫组织框架提供的响应性子维度的权重,计算出响应性总分,范围从0到100。结果:有效率为80.5%。反应性总分的平均(标准差)为57.18分(21.61分),中位数为56.71分。高学历被调查者的客户导向平均得分低于学历和学历以下的被调查者(P = 0.028)。结论:根据参与者的观点,超过一半的案例认为非医疗药学绩效为中等或高。在来访者方面,与受教育程度较低的患者相比,受教育程度高的患者倾向倾向较少。
{"title":"Assessing the Performance of Community Pharmacies in Iran by Measuring Responsiveness to Non-Medical Needs: An Application of WHO Responsiveness Framework.","authors":"Saba Afifi,&nbsp;Amir Hossein Alizadeh Bahmani,&nbsp;Leila Zarei,&nbsp;Motahareh Mahi-Birjand,&nbsp;Mehdi Hoorang,&nbsp;Marziyeh Zare,&nbsp;Iman Karimzadeh,&nbsp;Farzad Peiravian,&nbsp;Mahtabalsadat Mirjalili,&nbsp;Payam Peymani","doi":"10.4103/jrpp.JRPP_21_23","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_23","url":null,"abstract":"<p><strong>Objective: </strong>Despite growing debates about the health systems' nonmedical performance, there has not been any empirical research on nonmedical performance and patients' rights consideration as a driver of human rights in the pharmaceutical sector. This study's main objective was to assess the nonmedical performance of community pharmacies of Shiraz, Iran.</p><p><strong>Methods: </strong>A cross-sectional study was conducted using two self-administrated Likert-based questionnaires based on the World Health Organization (WHO) responsiveness framework and the legal charter communicated by the Ministry of Health and Medical Education of Iran. The population was patients older than 18 years who took a prescription from community pharmacies located in Shiraz and willing to answer the questions voluntarily, from 2018 to 2019. Considering the weights of subdimensions of responsiveness provided by the WHO framework, the total score of responsiveness was calculated ranging from 0 to 100.</p><p><strong>Findings: </strong>The response rate was 80.5%. The mean (standard deviation) overall score of responsiveness was 57.18 (21.61), with a median of 56.71. The mean score of client orientation was lower in respondents with a high education level than those with a diploma and under diploma (<i>P</i> = 0.028).</p><p><strong>Conclusion: </strong>Nonmedical pharmacy performance was considered either medium or high in more than half of the cases based on the participants' views. Regarding client, orientation was seen less often in patients with high education level compared to those with a lower education level.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"59-64"},"PeriodicalIF":1.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/e2/JRPP-10-59.PMC8420932.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Metabolic Acidosis in Multi Drug Poisoning with Antidepressants and Antipsychotics. 抗抑郁药和抗精神病药多重药物中毒的代谢性酸中毒。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-08-03 eCollection Date: 2021-04-01 DOI: 10.4103/jrpp.JRPP_20_106
Nastaran Eizadi-Mood, Saba Dehghanzad, Ali Mohammad Sabzghabaee, Ziba Farajzadegan

Objective: In this study, we evaluated the predictive factors for the occurrence of metabolic acidosis in patients with multi-drug poisoning, including antidepressants (Ad)/antipsychotics (Ap).

Methods: This cross-sectional study was carried out in the referral poisoning center, Khorshid University Hospital, affiliated with Isfahan University of Medical Sciences. All patients with multi-drug ingestion, including Ad/Ap, were included in the study. Patients were divided into two groups with and without metabolic acidosis. Demographic factors, time from ingestion to admission, clinical manifestations, length of hospital stay, and outcome were compared in two groups. Binary logistic regression was used to identify factors associated with the risk of metabolic acidosis occurrence.

Findings: Among the 206 evaluated patients, 45 patients (21.8%) had metabolic acidosis whom the majority were female (73.3%) with intentional purposes (77.8%). 31.1% of the patients with metabolic acidosis had tachycardia on admission (P = 0.03). Among all variables, time from ingestion to admission (P = 0.02) and lengths of hospital stay (P = 0.002) were significantly different between patients with and without metabolic acidosis. Tachycardia on admission (adjusted odds ratio [OR], 2.24; 95% confidence interval [CI]: 1.05-4.76; P = 0.036) and time from ingestion to admission (adjusted OR, 1.06; 95% CI: 1.00-1.13; P = 0.04) were also the predictive factors in occurrence of metabolic acidosis. Most of the patients survived without any complications (94.6%), of whom 72.3% had no previous underlying somatic diseases (P = 0.05).

Conclusion: Admission tachycardia and the time elapsed from ingestion to admission may be considered important factors for predicting metabolic acidosis in multi-drug poisoning, including Ad/Ap.

目的:本研究探讨包括抗抑郁药(Ad)/抗精神病药(Ap)在内的多药中毒患者代谢性酸中毒发生的预测因素。方法:本横断面研究在伊斯法罕医科大学附属科尔希德大学医院转诊中毒中心进行。包括Ad/Ap在内的所有多药摄入患者均被纳入研究。患者分为代谢性酸中毒和非代谢性酸中毒两组。比较两组患者的人口学因素、从摄入到入院的时间、临床表现、住院时间和转归。采用二元logistic回归来确定与代谢性酸中毒发生风险相关的因素。结果:206例患者中,代谢性酸中毒45例(21.8%),其中女性居多(73.3%),有故意目的(77.8%)。31.1%的代谢性酸中毒患者入院时出现心动过速(P = 0.03)。在所有变量中,代谢性酸中毒患者与非代谢性酸中毒患者从摄入到入院的时间(P = 0.02)和住院时间(P = 0.002)差异有统计学意义。入院时心动过速(校正优势比[OR], 2.24;95%置信区间[CI]: 1.05-4.76;P = 0.036)和从摄入到入院的时间(调整OR, 1.06;95% ci: 1.00-1.13;P = 0.04)也是代谢性酸中毒发生的预测因素。94.6%的患者无并发症,其中72.3%的患者既往无潜在躯体疾病(P = 0.05)。结论:多药中毒患者入院时心动过速及进食至入院时间可能是预测代谢性酸中毒的重要因素,包括Ad/Ap。
{"title":"Metabolic Acidosis in Multi Drug Poisoning with Antidepressants and Antipsychotics.","authors":"Nastaran Eizadi-Mood,&nbsp;Saba Dehghanzad,&nbsp;Ali Mohammad Sabzghabaee,&nbsp;Ziba Farajzadegan","doi":"10.4103/jrpp.JRPP_20_106","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_106","url":null,"abstract":"<p><strong>Objective: </strong>In this study, we evaluated the predictive factors for the occurrence of metabolic acidosis in patients with multi-drug poisoning, including antidepressants (Ad)/antipsychotics (Ap).</p><p><strong>Methods: </strong>This cross-sectional study was carried out in the referral poisoning center, Khorshid University Hospital, affiliated with Isfahan University of Medical Sciences. All patients with multi-drug ingestion, including Ad/Ap, were included in the study. Patients were divided into two groups with and without metabolic acidosis. Demographic factors, time from ingestion to admission, clinical manifestations, length of hospital stay, and outcome were compared in two groups. Binary logistic regression was used to identify factors associated with the risk of metabolic acidosis occurrence.</p><p><strong>Findings: </strong>Among the 206 evaluated patients, 45 patients (21.8%) had metabolic acidosis whom the majority were female (73.3%) with intentional purposes (77.8%). 31.1% of the patients with metabolic acidosis had tachycardia on admission (<i>P</i> = 0.03). Among all variables, time from ingestion to admission (<i>P</i> = 0.02) and lengths of hospital stay (<i>P</i> = 0.002) were significantly different between patients with and without metabolic acidosis. Tachycardia on admission (adjusted odds ratio [OR], 2.24; 95% confidence interval [CI]: 1.05-4.76; <i>P</i> = 0.036) and time from ingestion to admission (adjusted OR, 1.06; 95% CI: 1.00-1.13; <i>P</i> = 0.04) were also the predictive factors in occurrence of metabolic acidosis. Most of the patients survived without any complications (94.6%), of whom 72.3% had no previous underlying somatic diseases (<i>P</i> = 0.05).</p><p><strong>Conclusion: </strong>Admission tachycardia and the time elapsed from ingestion to admission may be considered important factors for predicting metabolic acidosis in multi-drug poisoning, including Ad/Ap.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"65-70"},"PeriodicalIF":1.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/9a/JRPP-10-65.PMC8420936.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adherence to Lipid-Lowering Medication in People Living with HIV: An Outpatient Clinic Drug Direct Distribution Experience. 艾滋病毒感染者坚持使用降脂药物:门诊药物直接分销经验。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-05-13 eCollection Date: 2021-01-01 DOI: 10.4103/jrpp.JRPP_20_96
Gianluca Cuomo, Alessandro Raimondi, Marianna Rivasi, Giovanni Guaraldi, Vanni Borghi, Cristina Mussini

Objective: Adherence to lipid-lowering drugs could be challenging in our patients as it is in the general population, which is described as low as 25%. Our aim was to evaluate adherence to statins and to investigate clinical event impact on it.

Methods: This retrospective study on HIV+ patients attending to Clinic of Modena (Italy) was conducted in order to evaluate characteristics, clinical events, and adherence on lipid-lowering drugs. All drugs for comorbidities are distributed by the hospital pharmacy and recorded in an electronical database. Adherence was also evaluated in patients who were supplied with antilipemics in external pharmacies through phone calls. Patients were considered adherent if the percentage of correct time of drug refill was >80%.

Findings: Totally 1123 patients were evaluated. Lipid-lowering drugs (statins, fenofibrate, and omega-3 oil) were prescribed in 242 patients (21.5%). Prescription occurred mainly in those who were older, males, and Italians. Two hundred of them (82.6%) used statins alone, 23 (9.5%) only fenofibrate or omega-3 oil, and 19 (7.8%) a combination of both drugs. The median adherence was 90% while patients with adherence >80% resulted 153 (63.2%). Forty-six (19%) had a clinical history of cardiovascular events; 59% of them, placed in secondary prophylaxis, and 76%, already in treatment, continued to adhere. No differences in terms of adherence according to the type of drug distribution (hospital pharmacy or outside pharmacies) were found.

Conclusion: Linking the supply of these drugs to that of antiretrovirals led to a good level of adherence higher than that described in the general population. The majority of the patients who experienced a cardiovascular event remain adherent to the prescribed therapy.

目的:我们的患者对降脂药物的依从性可能具有挑战性,就像普通人群一样,低至25%。我们的目的是评估他汀类药物的依从性,并调查临床事件对其的影响。所有治疗合并症的药物都由医院药房分发,并记录在电子数据库中。还通过电话评估了在外部药店接受抗脂药物治疗的患者的依从性。如果药物补充的正确时间百分比>80%,则患者被视为粘连。结果:共对1123例患者进行了评估。242名患者(21.5%)服用了降脂药物(他汀类药物、非诺贝特和ω-3油)。处方主要针对老年人、男性和意大利人。其中200人(82.6%)单独使用他汀类药物,23人(9.5%)仅使用非诺贝特或ω-3油,19人(7.8%)同时使用这两种药物。中位依从性为90%,而依从性>80%的患者有153例(63.2%)。46例(19%)有心血管事件的临床病史;其中59%的患者接受了二级预防,76%的患者已经接受了治疗,仍在坚持治疗。根据药物分销类型(医院药房或外部药房),在依从性方面没有发现差异。结论:将这些药物的供应与抗逆转录病毒药物的供应联系起来,可以获得比普通人群更高的良好依从性。大多数经历心血管事件的患者仍然坚持处方治疗。
{"title":"Adherence to Lipid-Lowering Medication in People Living with HIV: An Outpatient Clinic Drug Direct Distribution Experience.","authors":"Gianluca Cuomo,&nbsp;Alessandro Raimondi,&nbsp;Marianna Rivasi,&nbsp;Giovanni Guaraldi,&nbsp;Vanni Borghi,&nbsp;Cristina Mussini","doi":"10.4103/jrpp.JRPP_20_96","DOIUrl":"10.4103/jrpp.JRPP_20_96","url":null,"abstract":"<p><strong>Objective: </strong>Adherence to lipid-lowering drugs could be challenging in our patients as it is in the general population, which is described as low as 25%. Our aim was to evaluate adherence to statins and to investigate clinical event impact on it.</p><p><strong>Methods: </strong>This retrospective study on HIV+ patients attending to Clinic of Modena (Italy) was conducted in order to evaluate characteristics, clinical events, and adherence on lipid-lowering drugs. All drugs for comorbidities are distributed by the hospital pharmacy and recorded in an electronical database. Adherence was also evaluated in patients who were supplied with antilipemics in external pharmacies through phone calls. Patients were considered adherent if the percentage of correct time of drug refill was >80%.</p><p><strong>Findings: </strong>Totally 1123 patients were evaluated. Lipid-lowering drugs (statins, fenofibrate, and omega-3 oil) were prescribed in 242 patients (21.5%). Prescription occurred mainly in those who were older, males, and Italians. Two hundred of them (82.6%) used statins alone, 23 (9.5%) only fenofibrate or omega-3 oil, and 19 (7.8%) a combination of both drugs. The median adherence was 90% while patients with adherence >80% resulted 153 (63.2%). Forty-six (19%) had a clinical history of cardiovascular events; 59% of them, placed in secondary prophylaxis, and 76%, already in treatment, continued to adhere. No differences in terms of adherence according to the type of drug distribution (hospital pharmacy or outside pharmacies) were found.</p><p><strong>Conclusion: </strong>Linking the supply of these drugs to that of antiretrovirals led to a good level of adherence higher than that described in the general population. The majority of the patients who experienced a cardiovascular event remain adherent to the prescribed therapy.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"10-16"},"PeriodicalIF":1.0,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/31/b1/JRPP-10-10.PMC8259599.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39210676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Availability, Utilization, and Prices of Medicines and Protection Equipment for COVID-19 in an Urban Population of Northern Nigeria. 尼日利亚北部城市人口COVID-19药品和防护设备的可得性、使用情况和价格变化
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-05-13 eCollection Date: 2021-01-01 DOI: 10.4103/jrpp.JRPP_20_92
Mainul Haque, Abdullahi Rabiu Abubakar, Olayinka O Ogunleye, Ibrahim Haruna Sani, Israel Sefah, Amanj Kurdi, Salequl Islam, Brian Godman

Objective: Measures are ongoing to prevent the spread of COVID-19 and treat it with medicines and personal protective equipment (PPE). However, there has been considerable controversy surrounding treatments such as hydroxychloroquine with misinformation fuelling prices hikes and suicides. Shortages have also appreciably increased costs of PPE, potentially catastrophic among lower- and middle-income countries such as Nigeria with high copayment levels. Consequently, a need to investigate changes in availability, utilization, and prices of relevant medicines and PPE during the pandemic in Nigeria.

Methods: Exploratory study among community pharmacists with a survey tool comprising four sections including questions on changes in consumption, prices, and shortages of medicines and PPE from the beginning of March 2020 to the end of June 2020. In addition, suggestions from community pharmacists and co-authors on ways to reduce misinformation.

Findings: 30 out of 34 pharmacists participated giving a response rate of 88.2%. Significant increases were seen (3-fold or more increase) in the consumption of hydroxychloroquine (100%), vitamins/immune boosters (96.7%) and antibiotics (46.7%) as well as PPE (100%). Considerable price increases (50% increase or greater) also seen for antimalarials (96.7%), antibiotics (93.3%), vitamins/immune boosters (66.7%), and PPE (100%). Shortages are also seen for hydroxychloroquine and vitamins/immune boosters but most severe for PPE (80% of pharmacies).

Conclusion: Encouraging to see increases in the utilization of vitamins/immune boosters and PPE. However, a considerable increase in the utilization and prices of antimicrobials is a concern that needs addressing including misinformation. Community pharmacists have a key role in providing evidence-based advice and helping moderate prices.

目的:正在采取措施预防COVID-19的传播,并使用药物和个人防护装备(PPE)进行治疗。然而,关于羟氯喹等治疗方法,由于错误信息导致价格上涨和自杀,引发了相当大的争议。短缺也明显增加了个人防护装备的成本,这在尼日利亚等共同支付水平较高的中低收入国家可能是灾难性的。因此,有必要调查尼日利亚大流行期间相关药品和个人防护装备的可得性、使用情况和价格的变化。方法:采用调查工具对社区药师进行探索性研究,调查工具包括2020年3月初至2020年6月底药品和个人防护用品的消费变化、价格变化、短缺情况等四个部分。此外,社区药剂师和合著者对减少错误信息的方法提出了建议。结果:34名药师中有30名参与,有效率为88.2%。羟基氯喹(100%)、维生素/免疫增强剂(96.7%)和抗生素(46.7%)以及个人防护用品(100%)的消费量显著增加(增加3倍或更多)。抗疟药(96.7%)、抗生素(93.3%)、维生素/免疫增强剂(66.7%)和个人防护装备(100%)的价格也大幅上涨(上涨50%或更多)。羟氯喹和维生素/免疫增强剂也出现短缺,但个人防护装备短缺最为严重(80%的药店)。结论:令人鼓舞的是,维生素/免疫增强剂和个人防护用品的使用有所增加。然而,抗菌素的使用和价格的大幅增加是一个需要解决的问题,包括错误信息。社区药剂师在提供循证咨询和帮助调节价格方面发挥着关键作用。
{"title":"Changes in Availability, Utilization, and Prices of Medicines and Protection Equipment for COVID-19 in an Urban Population of Northern Nigeria.","authors":"Mainul Haque,&nbsp;Abdullahi Rabiu Abubakar,&nbsp;Olayinka O Ogunleye,&nbsp;Ibrahim Haruna Sani,&nbsp;Israel Sefah,&nbsp;Amanj Kurdi,&nbsp;Salequl Islam,&nbsp;Brian Godman","doi":"10.4103/jrpp.JRPP_20_92","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_92","url":null,"abstract":"<p><strong>Objective: </strong>Measures are ongoing to prevent the spread of COVID-19 and treat it with medicines and personal protective equipment (PPE). However, there has been considerable controversy surrounding treatments such as hydroxychloroquine with misinformation fuelling prices hikes and suicides. Shortages have also appreciably increased costs of PPE, potentially catastrophic among lower- and middle-income countries such as Nigeria with high copayment levels. Consequently, a need to investigate changes in availability, utilization, and prices of relevant medicines and PPE during the pandemic in Nigeria.</p><p><strong>Methods: </strong>Exploratory study among community pharmacists with a survey tool comprising four sections including questions on changes in consumption, prices, and shortages of medicines and PPE from the beginning of March 2020 to the end of June 2020. In addition, suggestions from community pharmacists and co-authors on ways to reduce misinformation.</p><p><strong>Findings: </strong>30 out of 34 pharmacists participated giving a response rate of 88.2%. Significant increases were seen (3-fold or more increase) in the consumption of hydroxychloroquine (100%), vitamins/immune boosters (96.7%) and antibiotics (46.7%) as well as PPE (100%). Considerable price increases (50% increase or greater) also seen for antimalarials (96.7%), antibiotics (93.3%), vitamins/immune boosters (66.7%), and PPE (100%). Shortages are also seen for hydroxychloroquine and vitamins/immune boosters but most severe for PPE (80% of pharmacies).</p><p><strong>Conclusion: </strong>Encouraging to see increases in the utilization of vitamins/immune boosters and PPE. However, a considerable increase in the utilization and prices of antimicrobials is a concern that needs addressing including misinformation. Community pharmacists have a key role in providing evidence-based advice and helping moderate prices.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"17-22"},"PeriodicalIF":1.0,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/35/a5/JRPP-10-17.PMC8259594.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39210677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
The Safety and Effectiveness of Pharmacotherapy for Opioid-Overdose Induced Aspiration Pneumonia in a Referral Poisoning Management University Hospital in Iran. 伊朗一家转诊中毒管理大学医院阿片类药物过量致吸入性肺炎药物治疗的安全性和有效性
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-05-13 eCollection Date: 2021-01-01 DOI: 10.4103/jrpp.JRPP_21_17
Mohammadreza Tabatabaei, Gholamali Dorvashy, Rasoul Soltani, Shiva Samsamshariat, Rokhsareh Meamar, Ali Mohammad Sabzghabaee

Objective: Opioid abuse is widespread throughout the world. Aspiration pneumonia is a serious problem following opioid overdose and poisoning. This study aimed to evaluate the safety and effectiveness of antimicrobial management of opioid-overdose induced aspiration pneumonia in a referral poisoning management university hospital in Iran.

Methods: In an observational cross-sectional study (September-March 2019), opioid poisoned patients diagnosed with aspiration pneumonia within a maximum of 48 h of their overdose were evaluated regarding several variables, including the level of consciousness on admission, drug regimen used for the treatment of aspiration pneumonia, and its appropriateness, and the correctness of the used antibiotics dose and the therapeutic outcome.

Findings: During the study, 53 eligible patients were identified and included in the study. The most frequently abused opioids were methadone (60.4%) and opium (17%). "Ceftriaxone + Clindamycin" (54.7%) and "Meropenem + Vancomycin" (9.5%) were the most frequently administered regimens. Regarding treatment outcome, most cases (n = 36, 67.9%) were discharged with a stable and satisfying medical status, while 3.8% of the cases (n = 2) died.

Conclusion: The use of antibiotics in the treatment of aspiration pneumonia in hospitalized patients with opioid overdose in our referral university hospital is associated with notable antibiotic regimen choice issues. The implementation of strategies for improving the pattern of antibiotic prescribing for these patients is necessary.

目的:阿片类药物滥用在世界范围内普遍存在。吸入性肺炎是阿片类药物过量和中毒后的严重问题。本研究旨在评估伊朗一家转诊中毒管理大学医院阿片类药物过量引起的吸入性肺炎抗菌管理的安全性和有效性。方法:在一项观察性横断面研究(2019年9月- 3月)中,对过量服用阿片类药物后48小时内诊断为吸入性肺炎的阿片类药物中毒患者进行评估,包括入院时的意识水平、治疗吸入性肺炎的药物方案及其适宜性、使用抗生素剂量的准确性和治疗结果。研究结果:在研究期间,53名符合条件的患者被确定并纳入研究。最常滥用的阿片类药物是美沙酮(60.4%)和鸦片(17%)。“头孢曲松+克林霉素”(54.7%)和“美罗培南+万古霉素”(9.5%)是最常用的方案。在治疗结果方面,大多数病例(n = 36, 67.9%)出院时病情稳定满意,3.8%的病例(n = 2)死亡。结论:我院转诊医院阿片类药物过量住院患者吸入性肺炎的抗生素使用存在明显的抗生素方案选择问题。实施改善这些患者抗生素处方模式的策略是必要的。
{"title":"The Safety and Effectiveness of Pharmacotherapy for Opioid-Overdose Induced Aspiration Pneumonia in a Referral Poisoning Management University Hospital in Iran.","authors":"Mohammadreza Tabatabaei,&nbsp;Gholamali Dorvashy,&nbsp;Rasoul Soltani,&nbsp;Shiva Samsamshariat,&nbsp;Rokhsareh Meamar,&nbsp;Ali Mohammad Sabzghabaee","doi":"10.4103/jrpp.JRPP_21_17","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_17","url":null,"abstract":"<p><strong>Objective: </strong>Opioid abuse is widespread throughout the world. Aspiration pneumonia is a serious problem following opioid overdose and poisoning. This study aimed to evaluate the safety and effectiveness of antimicrobial management of opioid-overdose induced aspiration pneumonia in a referral poisoning management university hospital in Iran.</p><p><strong>Methods: </strong>In an observational cross-sectional study (September-March 2019), opioid poisoned patients diagnosed with aspiration pneumonia within a maximum of 48 h of their overdose were evaluated regarding several variables, including the level of consciousness on admission, drug regimen used for the treatment of aspiration pneumonia, and its appropriateness, and the correctness of the used antibiotics dose and the therapeutic outcome.</p><p><strong>Findings: </strong>During the study, 53 eligible patients were identified and included in the study. The most frequently abused opioids were methadone (60.4%) and opium (17%). \"Ceftriaxone + Clindamycin\" (54.7%) and \"Meropenem + Vancomycin\" (9.5%) were the most frequently administered regimens. Regarding treatment outcome, most cases (<i>n</i> = 36, 67.9%) were discharged with a stable and satisfying medical status, while 3.8% of the cases (<i>n</i> = 2) died.</p><p><strong>Conclusion: </strong>The use of antibiotics in the treatment of aspiration pneumonia in hospitalized patients with opioid overdose in our referral university hospital is associated with notable antibiotic regimen choice issues. The implementation of strategies for improving the pattern of antibiotic prescribing for these patients is necessary.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"38-42"},"PeriodicalIF":1.0,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ec/08/JRPP-10-38.PMC8259600.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39210680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Research in Pharmacy Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1